BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 29898218)

  • 1. Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.
    Martin SS; Giugliano RP; Murphy SA; Wasserman SM; Stein EA; Ceška R; López-Miranda J; Georgiev B; Lorenzatti AJ; Tikkanen MJ; Sever PS; Keech AC; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2018 Aug; 3(8):749-753. PubMed ID: 29898218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.
    Sajja A; Park J; Sathiyakumar V; Varghese B; Pallazola VA; Marvel FA; Kulkarni K; Muthukumar A; Joshi PH; Gianos E; Hirsh B; Mintz G; Goldberg A; Morris PB; Sharma G; Blumenthal RS; Michos ED; Post WS; Elshazly MB; Jones SR; Martin SS
    JAMA Netw Open; 2021 Oct; 4(10):e2128817. PubMed ID: 34709388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Low LDL Cholesterol in Patients Treated by PCSK9 Inhibition: Comparison of Martin/Hopkins and Friedewald Estimations.
    Egbaria A; Saliba W; Zafrir B
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):787-792. PubMed ID: 33226544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition.
    Martin SS; Ditmarsch M; Simmons M; Alp N; Turner T; Davidson MH; Kastelein JJP
    Eur Heart J Cardiovasc Pharmacother; 2023 Feb; 9(2):148-155. PubMed ID: 36307922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.
    Martin SS; Blaha MJ; Elshazly MB; Toth PP; Kwiterovich PO; Blumenthal RS; Jones SR
    JAMA; 2013 Nov; 310(19):2061-8. PubMed ID: 24240933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis.
    Sajja A; Li HF; Spinelli KJ; Blumenthal RS; Virani SS; Martin SS; Gluckman TJ
    J Am Coll Cardiol; 2022 Feb; 79(6):530-541. PubMed ID: 35144744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.
    Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
    Clin Biochem; 2019 Feb; 64():24-29. PubMed ID: 30365923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.
    Whelton SP; Meeusen JW; Donato LJ; Jaffe AS; Saenger A; Sokoll LJ; Blumenthal RS; Jones SR; Martin SS
    J Clin Lipidol; 2017; 11(4):1065-1072. PubMed ID: 28826567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab.
    Desai NR; Giugliano RP; Wasserman SM; Gibbs JP; Liu T; Scott R; Sabatine MS
    JAMA Cardiol; 2017 May; 2(5):556-560. PubMed ID: 28122070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data.
    Qamar A; Giugliano RP; Keech AC; Kuder JF; Murphy SA; Kurtz CE; Wasserman SM; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2019 Jan; 4(1):59-63. PubMed ID: 30540337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory and Cholesterol Risk in the FOURIER Trial.
    Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
    Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.
    Samuel C; Park J; Sajja A; Michos ED; Blumenthal RS; Jones SR; Martin SS
    Glob Heart; 2023; 18(1):36. PubMed ID: 37361322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study.
    Koren MJ; Sabatine MS; Giugliano RP; Langslet G; Wiviott SD; Kassahun H; Ruzza A; Ma Y; Somaratne R; Raal FJ
    JAMA Cardiol; 2017 Jun; 2(6):598-607. PubMed ID: 28291870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011.
    Lee J; Jang S; Son H
    PLoS One; 2016; 11(1):e0148147. PubMed ID: 26824910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.
    Singh G; Hussain Y; Xu Z; Sholle E; Michalak K; Dolan K; Lee BC; van Rosendael AR; Fatima Z; Peña JM; Wilson PWF; Gotto AM; Shaw LJ; Baskaran L; Al'Aref SJ
    PLoS One; 2020; 15(9):e0239934. PubMed ID: 32997716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of Martin-Hopkins formula and comparison with Friedewald formula for estimated low-density lipoprotein cholesterol in e_COR study population.
    Ferrinho C; Alves AC; Bourbon M; Duarte S
    Rev Port Cardiol (Engl Ed); 2021 Oct; 40(10):715-724. PubMed ID: 34857108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative performance of equations to estimate low-density lipoprotein cholesterol levels and cardiovascular disease incidence: The ATTICA study (2002-2022).
    Nomikos T; Georgoulis M; Chrysohoou C; Damigou E; Barkas F; Skoumas I; Liberopoulos E; Pitsavos C; Tsioufis C; Sfikakis PP; Tselepis A; Panagiotakos DB
    Lipids; 2023 Jul; 58(4):159-170. PubMed ID: 37153959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.
    Martin SS; Blaha MJ; Elshazly MB; Brinton EA; Toth PP; McEvoy JW; Joshi PH; Kulkarni KR; Mize PD; Kwiterovich PO; Defilippis AP; Blumenthal RS; Jones SR
    J Am Coll Cardiol; 2013 Aug; 62(8):732-9. PubMed ID: 23524048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of extended Martin/Hopkins equation with a direct homogeneous assay in assessing low-density lipoprotein cholesterol in patients with hypertriglyceridemia.
    Chung S
    J Clin Lab Anal; 2023 Sep; 37(17-18):e24963. PubMed ID: 37679962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.